2005
Risk of HIV/AIDS in China: subpopulations of special importance
Qian Z, Vermund SH, Wang N. Risk of HIV/AIDS in China: subpopulations of special importance. Sexually Transmitted Infections 2005, 81: 442. PMID: 16326842, PMCID: PMC1745065, DOI: 10.1136/sti.2004.014258.Peer-Reviewed Original ResearchConceptsHIV/AIDS epidemicHIV/AIDSDrug usersAIDS epidemicFormidable treatment challengeInjection drug useSex workersMajor risk factorLow condom useCommercial plasma donationCommercial sex workersNew drug usersHigh-risk behaviorsRed blood cellsHIV infectionNeedle sharingRisk factorsRisk groupsTreatment challengesFuture HIVGeneral populationHomosexual menDrug useUnprotected sexCondom use
1994
Incidence Of Clinical Aids Conditions In A Cohort Of Homosexual Men With CD4+ Cell Counts <100/mm3
Bacellar H, Muñoz A, Hoover D, Phair J, Besley D, Kingsley L, Vermund S, Study F. Incidence Of Clinical Aids Conditions In A Cohort Of Homosexual Men With CD4+ Cell Counts <100/mm3. The Journal Of Infectious Diseases 1994, 170: 1284-1287. PMID: 7963728, DOI: 10.1093/infdis/170.5.1284.Peer-Reviewed Original ResearchConceptsIncidence rateHomosexual menCD4 cells/mm3P. carinii pneumonia prophylaxisHuman immunodeficiency virus type 1Multicenter AIDS Cohort StudyImmunodeficiency virus type 1Cells/mm3Use of antiretroviralsPneumocystis carinii pneumoniaAIDS Cohort StudyHealth care providersMycobacterium avium complexVirus type 1Cytomegalovirus diseasePneumonia prophylaxisCytomegalovirus retinitisAIDS illnessCohort studyOpportunistic infectionsAIDS conditionsCarinii pneumoniaClinical trialsKaposi's sarcomaCare providers
1993
Depressive Symptoms as Predictors of Medical Outcomes in HIV Infection
Lyketsos C, Hoover D, Guccione M, Senterfitt W, Dew M, Wesch J, VanRaden M, Treisman G, Morgenstern H, Saah A, Palenicek J, Armenian H, Farzadegan H, Graham N, Margolick J, McArthur J, Phair J, Chmiel J, Cohen B, O'Gorman M, Variakojis D, Wesch J, Wolinsky S, Detels R, Visscher B, Chen I, Dudley J, Fahey J, Giorgi J, Lee M, Martinez-Mara O, Miller E, Nishanian P, Taylor J, Zack J, Rinaldor C, Kingsley L, Becker J, Gupta P, Ho M, Muñoz A, Jacobson L, Beaty T, Galai N, Epstein L, Guccione M, Hoover D, Meinert C, Nelson K, Piantadosi S, Su S, Schrager L, Vermund S, Kaslow R, VanRaden M, Seminara D. Depressive Symptoms as Predictors of Medical Outcomes in HIV Infection. JAMA 1993, 270: 2563-2567. DOI: 10.1001/jama.1993.03510210049026.Peer-Reviewed Original ResearchHuman immunodeficiency virusCD4 countCohort studyHIV infectionDepressive symptomsMedical outcomesEight-year cohort studyHIV-seropositive homosexual menMulticenter AIDS Cohort StudyLow CD4 countEpidemiologic Studies Depression ScaleAssociation of depressionEight-year followWorse medical outcomesAIDS Cohort StudyHIV outcomesImmunodeficiency syndromeImmunodeficiency virusProphylactic treatmentEligible participantsWorse outcomesMore AIDSOutcome measuresHomosexual menSymptoms
1991
The unseen sample in cohort studies: Estimation of its size and effect
Hoover DR, Muñoz A, Carey V, Odaka N, Taylor J, Chmiel JS, Armstrong J, Vermund SH. The unseen sample in cohort studies: Estimation of its size and effect. Statistics In Medicine 1991, 10: 1993-2003. PMID: 1805323, DOI: 10.1002/sim.4780101212.Peer-Reviewed Original ResearchEstimating the 1978–1990 and Future Spread of Human Immunodeficiency Virus Type 1 in Subgroups of Homosexual Men
Hoover D, Munoz A, Carey V, Chmiel J, Taylor J, Margolick J, Kingsley L, Vermund S. Estimating the 1978–1990 and Future Spread of Human Immunodeficiency Virus Type 1 in Subgroups of Homosexual Men. American Journal Of Epidemiology 1991, 134: 1190-1205. PMID: 1746529, DOI: 10.1093/oxfordjournals.aje.a116022.Peer-Reviewed Original ResearchConceptsSeroconversion ratesHomosexual menHuman immunodeficiency virus type 1 (HIV-1) infectionHuman immunodeficiency virus type 1Virus type 1 infectionImmunodeficiency virus type 1Kaplan-Meier methodHIV-1 infectionType 1 infectionAge 55 yearsHIV-1 epidemicVirus type 1AIDS diagnosisSeroconversionAnnual hazardHematologic variablesAge 55Type 1Survival methodsBisexual menHomosexual populationCohortMenAgeInfectionZidovudine use in AIDS-free HIV-1-seropositive homosexual men in the Multicenter AIDS Cohort Study (MACS), 1987-1989.
Graham NM, Zeger SL, Kuo V, Jacobson LP, Vermund SH, Phair JP, Detels R, Rinaldo CR, Saah AJ. Zidovudine use in AIDS-free HIV-1-seropositive homosexual men in the Multicenter AIDS Cohort Study (MACS), 1987-1989. JAIDS Journal Of Acquired Immune Deficiency Syndromes 1991, 4: 267-76. PMID: 1671411.Peer-Reviewed Original ResearchConceptsHIV-1 seropositive homosexual menZidovudine useVisit 11Clinical variablesClinical trialsHomosexual menVisit 7Multicenter AIDS Cohort StudyLymphocytes/mm3Major clinical variablesClinical trial participationAIDS Cohort StudyClinical trial participantsSeropositive participantsZidovudine therapyCohort studyHigher treatment ratesLymphocyte levelsLymphocyte numbersNonclinical factorsAIDS patientsTrial participationSymptom statusOverall prevalenceOdds ratio